Immunomedics Reports Progress With Labeling Proteins, Including Antibodies ... GlobeNewswire (press release) VANCOUVER, British Columbia, June 12, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, ... |
